Data supplements
Supplemental Data - Hein, P. A. et al.
Supplemental material for Hein, PA, Eskey, CJ, Dunn, JF, and Hug, EB. Diffusion-Weighted Imaging in the Follow-up of Treated High-Grade Gliomas: Tumor Recurrence versus Radiation Injury. AJNR Am J Neuroradiol 2004;25:201-209
Note: Adobe Acrobat Reader is required to view tables and is available for free download at http://www.adobe.com/products/acrobat/readstep2.html
Files in this Data Supplement:
- Table 1 (14.7KB) - Summary of patient-, tumor-, and treatment- characteristics, and radiologic diagnostic modalities
- Table 2 (11.4KB) - Time to MRI enhancement after completion of radiation therapy, subsequent clinical course, and radiographic development
- Table 3 (13.9KB) - Mean ADC's in the enhancing lesion, contralateral hemisphere, T2 prolongation, and results of normalization
In this issue
Jump to section
Related Articles
Cited By...
- Tissue Hypoxia and Alterations in Microvascular Architecture Predict Glioblastoma Recurrence in Humans
- Centrally Reduced Diffusion Sign for Differentiation between Treatment-Related Lesions and Glioma Progression: A Validation Study
- Quantitation of brain tumour microstructure response to Temozolomide therapy using non-invasive VERDICT MRI
- Sequential Apparent Diffusion Coefficient for Assessment of Tumor Progression in Patients with Low-Grade Glioma
- MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter
- Diagnostic Accuracy of Centrally Restricted Diffusion in the Differentiation of Treatment-Related Necrosis from Tumor Recurrence in High-Grade Gliomas
- Differentiation between Radiation Necrosis and Tumor Progression Using Chemical Exchange Saturation Transfer
- Although Non-diagnostic Between Necrosis and Recurrence, FDG PET/CT Assists Management of Brain Tumours After Radiosurgery
- Independent Poor Prognostic Factors for True Progression after Radiation Therapy and Concomitant Temozolomide in Patients with Glioblastoma: Subependymal Enhancement and Low ADC Value
- Diffusion and Perfusion MRI to Differentiate Treatment-Related Changes Including Pseudoprogression from Recurrent Tumors in High-Grade Gliomas with Histopathologic Evidence
- Clinical applications of imaging biomarkers. Part 3. The neuro-oncologist's perspective
- Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours
- Distinguishing Recurrent Primary Brain Tumor from Radiation Injury: A Preliminary Study Using a Susceptibility-Weighted MR Imaging-Guided Apparent Diffusion Coefficient Analysis Strategy
- Apparent Diffusion Coefficient of Glial Neoplasms: Correlation with Fluorodeoxyglucose-Positron-Emission Tomography and Gadolinium-Enhanced MR Imaging
- MR Spectroscopy in Radiation Injury
- Closing the Uncertainty Gap in the Diagnosis of Parotid Tumors
- Distinguishing Recurrent Intra-Axial Metastatic Tumor from Radiation Necrosis Following Gamma Knife Radiosurgery Using Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging
- Evaluation of the larynx for tumour recurrence by diffusion-weighted MRI after radiotherapy: initial experience in four cases
- Usefulness of diffusion/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading?
- Diagnosis and Treatment of Recurrent High-Grade Astrocytoma